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Hemoglobin (Hb) is a highly conserved molecule present in all life forms and functionally
tied to the complexity of aerobic organisms on earth in utilizing oxygen from the
atmosphere and delivering to cells and tissues. This primary function sustains the energy
requirements of cells and maintains cellular homeostasis. Decades of intensive research
has presented a paradigm shift that shows how the molecule also functions to facilitate
smooth oxygen delivery through the cardiovascular system for cellular bioenergetic
homeostasis and signaling for cell function and defense. These roles are particularly
highlighted in the binding of Hb to gaseous molecules carbon dioxide (CO2), nitric
oxide (NO) and carbon monoxide (CO), while also serving indirectly or directly as
sources of these signaling molecules. The functional activities impacted by Hb outside
of bioenergetics homeostasis, include fertilization, signaling functions, modulation of
inflammatory responses for defense and cell viability. These activities are efficiently
executed while Hb is sequestered safely within the confines of the red blood cell (rbc).
Outside of rbc confines, Hb disaggregates and becomes a danger molecule to cell
survival. In these perpectives, Hb function is broadly dichotomous, either a friend in its
natural environment providing and facilitating the means for cell function or foe when
dislocated from its habitat under stress or pathological condition disrupting cell function.
The review presents insights into how this dichotomy in function manifests.
Keywords: hemoglobin, gaseous molecules, intravascular and extravascular hemolysis, inflammation, ROS
Introduction
Hemoglobin (Hb), a protein that is found in all life forms was discovered by F L Hunefeld in
1840 at Liepzig University (Sheftel et al., 2012). It consists of a prosthetic heme molecule [Fe
II coordinated to a tetrapyrole ring (protoporphyrin IX)] joined to globin chains (Schechter,
2008, 2012). Vincenzo Menghini first established that iron in blood is concentrated in the rbc
(Busacchi, 1958). Depending on the species or organism Hb functions to transport or store oxy-
gen, offer protection against reactive oxygen species and detoxify nitric oxide (NO), nitrite and
peroxides (Nishi et al., 2008; Schechter, 2008; Tiso et al., 2011). In humans and vertebrates,
it lies at the cross road of energy transduction from the external environment to the internal
milieu of living systems. Its concentration in blood is 150 g/l so that an adult human body con-
tains approximately 1 kg of Hb (Olsson et al., 2012)The functional activities of hemoglobin are
essentially dichotomous: (a) to provide a means for binding to oxygen and facilitate its deliv-
ery for cellular bioenergetics homeostasis, (b) to be a direct or indirect source of other gaseous
molecules, bind to them and in the process moderate red blood cell (rbc) and cellular health,
function, defense or damage to the cells. These activities are friendly, salutary and sustaining to cell
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health and tissue homeostasis when considered vis-à-vis the high
concentration of hemoglobin in rbc or outright inimical to cell
survival. This review will first present an overview of the gen-
eral function and reactivity of Hb highlighting aspects that are
friendly to cell health and those that are foe like and damaging.
The later part will then have a detailed presentation on the syn-
thesis of hemoglobin in humans, its importance for cell function
in relation to binding to gaseousmolecules and the harm it causes
when released outside of its confinement in rbc.
General Hb Function and Reactivity
The history of life on earth is closely linked to the evolution of
oxygen supply in the atmosphere. This link is central to energy
needs of cells and cellular homeostasis in energy transforma-
tion (Taylor and Cummins, 2011).The evolution of cyanobacteria
with the potential of harnessing energy from the sun with trans-
duction into stored macromolecules in photosynthesis and the
release of oxygen, started the process of oxygenation of the atmo-
sphere on the earth (Semenza, 2007). Life forms with increas-
ing complexity including humans have adapted to oxygen usage
through Hb in respiration where oxygen serves as the final elec-
tron acceptor in the electron transport chain, localized within the
mitochondrion (Rich, 2003). While the structure of Hb is opti-
mal to capture oxygen and deliver it to the tissues, it also presents
a challenge of auto-oxidation that can modify its structure and
lead to generation of reactive oxygen species (ROS) and cellular
damage (Reeder et al., 2008). This dichotomy in function makes
hemoglobin a double edged sword with one face as a friend and
the other a foe under stress.
The primary function of Hb in the capture and release of oxy-
gen is facilitated by heme (with Fe II) which also enables the
reversible binding of carbon monoxide (CO) and NO through
heme based sensor proteins (Chay and Brillhart, 1974; Girvan
and Munro, 2013) while binding of carbon dioxide (CO2) is
allosterically regulated in a heterotropic interaction with the ter-
minal α-amino groups of Hb through rbc band 3 protein com-
plex and soluble adenylcyclase sensing (sAC) (Bauer and Kurtz,
1977; De Rosa et al., 2008; Buck and Levin, 2011). The binding of
hemoglobin to oxygen molecule does not lead to a change in the
oxidative state of iron (Rifkind and Nagababu, 2013). However,
because at physiological pH oxygen has a higher redox poten-
tial than Fe, sometimes hemoglobin undergoes auto-oxidation
with oxygen being reduced to the superoxide anion (O·−2 ) and
generation of metHb/hemin (Fe3+) (Bonaventura et al., 2013).
This reaction is particularly enhanced under hypoxia (Abugo and
Rifkind, 1994). In hemin/metHb, the binding affinity of globin
to heme is weak and can lead to loss of heme. This activity is
known to affect about 1–3% of Hb under normal physiolog-
ical conditions (Alayash, 2004). The generation of superoxide
and hemin may be beneficial or detrimental, but the release of
heme from Hb binding can be damaging when in excess (Aft and
Mueller, 1983; Schmitt et al., 1993; Girvan and Munro, 2013).
Superoxide being a reactive oxygen species (ROS) is important
for signaling function under normal physiology when present in
moderate amounts (Reth, 2002; Taniyama and Griendling, 2003).
Similarly hemin has a net positive charge, so it can react with
nitrites (anions) whether in oxyhemoglobin or deoxyhemoglobin
to regenerate hemin and NO (Cosby et al., 2003; Huang et al.,
2005). Because hemin is unable to bind oxygen, it does not take
part in oxygen transport. NO on the other hand is important for
signaling functions, regulation of vascular tone, modulation of
the immune response and moderation of endothelial adhesion
molecule expression among others (Guzik et al., 2003; Forster-
mann and Sessa, 2012). So a limited release of heme under normal
circumstances is useful. In addition anti-oxidants in the rbc or in
circulation are able to offset any potentially harmful degradative
products. These include glutathione, ascorbic acid, glutathione
peroxidase and peroxiredoxin in the rbc (Ascenzi et al., 2005;
Lutz and Bogdanova, 2013). In circulation the major scavengers
that limit hemoglobin and heme damage are haptoglobin and
hemopexin respectively (Nielsen and Moestrup, 2009; Reeder,
2010; Tolosano et al., 2010; Belcher et al., 2013; Schaer et al.,
2014). However, under stress or pathological conditions, the
moderating effect of the scavengers is overwhelmed so that a cas-
cade of ROS generated fromHb auto-oxidation is not dampened.
In that circumstance NO can react with superoxide to generate
peroxynitrite (ONOO−) which sets up a cascade of ROS gen-
eration that are damaging to cells and tissues (Griendling and
FitzGerald, 2003; Pacher et al., 2007). This is augmented by the
release of heme intravascularly or extravascularly (Schaer et al.,
2013).
Hemoglobin binding to CO and CO2 also serves impor-
tant signaling functions (Maines, 1997; Otterbein et al., 2000;
Schechter, 2008). CO has been shown as a signaling molecule
in the brain, a messenger molecule in the gastrointestinal tract,
and an inducer of hyperpolarization in circular smooth muscle
cells (Maines, 1997; Amano and Camara, 2013). CO2 which is
produced largely in the TCA cycle in cellular metabolism affects
tissue homeostasis (e.g., disrupted pH changes) that can lead
to death or play an important role in inhibiting inflammation
(Buck and Levin, 2011; Cummins et al., 2014). So Hb not only
ensures cellular energy supply through oxygen delivery, but also
facilitates cellular homeostasis through signaling functions of the
gases to which it binds. These functional activities of hemoglobin
are friendly, sustaining and salubrious to cell health and tissue
homeostasis when considered vis-à-vis the high concentration
of hemoglobin in rbc. The review will presently give details on
the synthesis of hemoglobin in humans, its importance for cell
function and the harm it causes when released outside of its
confinement in rbc.
Human Hemoglobin Synthesis
Human hemoglobin is produced in erythroid cells and in adults
is made up of two major tetramers, HbA (97%) consisting of two
alpha and two beta globin polypeptides (α2β2) and HbA2 (2%)
consisting of two alpha and two delta globin polypeptides (α2δ2)
(Perutz, 1979). In the fetus, the Hb molecule referred to as HbF
consists of two alpha and two gamma chains (α2γ2). This pheno-
type can be present in adults up to 1% (Schechter, 2008). After
birth, the gamma chains are replaced with beta chains gradually
(Perutz, 1979).
The genes for the alpha globin chains are located on chro-
mosome 16 whereas chromosome 11 harbors the genes for the
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beta globin chains (Huehns et al., 1964). During ontogenesis, the
embryonic alpha chains (ζ) are replaced by the adult type (α)
which is maintained throughout adulthood (Huehns et al., 1964).
However, the expression of the genes for the globin chains in ery-
throid cells differ based on the developmental stage. The β-globin
genes are arranged sequentially from the 5′ region closest to
the locus control region (LCR), in the order in which they are
expressed during ontogenesis toward the 3′ region (Huehns et al.,
1964). This order is ε (HBE), Gγ(HBG2), Aγ(HBG1), δ(HBD),
and β(HBB)-3′) expressed depending on switches in gene expres-
sion (Figure 1) (Huehns et al., 1964). These switches are from
embryonic (HBE) to fetal (HBG2 and HBG1) stage and fetal to
adult stage (HBD and HBB), regulated by the LCR of the globin
gene cluster (Schechter, 2008; Razin et al., 2012; Moleirinho et al.,
2013). The HBB gene is more highly expressed in adults than the
HBD gene which is why adult hemoglobin is made up largely
(97%) of HbA and about 2% of HbA2. The prosthetic group heme
is synthesized through a series of eight step enzymatic reactions
half of which occurs in the cytosol and a half in mitochondria
(Heinemann et al., 2008; Chiabrando et al., 2014). After the final
step which occurs in the mitochondria matrix, heme is targeted
into hemoproteins either membrane bound or in the cytosol
(Schultz et al., 2010; Larsen et al., 2012; Korolnek and Hamza,
2014). Hemoglobin and myoglobin acquire heme in the cytosol
(Bruns and London, 1965). In these compounds heme (type b) is
non-covalently coordinated to each globin chain (alpha and beta)
through Fe II. It is postulated that heme acquired into cytosolic
globin molecules may be derived frommitochondria or imported
through plasma membrane importers or the endocytic pathway
(Wu et al., 2006; Korolnek and Hamza, 2014).
The Friendly Role of Hemoglobin in Cell
Physiology
The friendly role of Hb is defined in part by its ability to bind
gases in particular O2, NO, CO and CO2 for transport. The bind-
ing affinity of the gases to Hb through heme are in the order
NO>>CO>> O2 (Chapman and Cokelet, 1997; Reeder, 2010;
Olsson et al., 2012). This activity is fundamental to the survival of
multicellular organisms. Indeed the principal function of the car-
diovascular system is essentially to deliver oxygen and nutrients,
while facilitating the removal of carbon dioxide and metabolic
waste in the process (Mairbaurl and Weber, 2012).
Hemoglobin and O2
The transport of oxygen from the lungs to tissues is mediated
by the Hb tetramer with heme iron in the ferrous state (Fe2+)
binding four oxygenmolecules (Reedy andGibney, 2004; Ascenzi
et al., 2005; Buehler and Alayash, 2005). In the lungs oxygen dif-
fuses across the alveolar barrier into the blood where it is bound
by Hb (Eaton, 1974). Through the activity of the cardiovascular
system, oxygen is delivered into tissues by way of the micro-
circulation comprising the arterioles, venules and capillaries to
maintain cellular bioenergetics homeostasis (Haldar and Stam-
ler, 2013). The blood oxygen content which invariably depends
on hemoglobin oxygen saturation determines the amount of oxy-
gen delivered to tissues (Mairbaurl and Weber, 2012; Haldar and
Stamler, 2013). A decrease in pH or an increase in the partial
pressure of CO2 (P CO2) in the systemic capillaries decreases the
affinity of oxygen for Hb (Bohr Effect) leading to tissue deliv-
ery of oxygen (Dash and Bassingthwaighte, 2006). Tissue oxygen
gradient in turn regulates blood flow in the microcirculation, lev-
els of erythropoietin synthesized for erythropoiesis and oxygen
delivery (Siri et al., 1966; Hebbel et al., 1978). Hypoxia defined
as decreased oxygen levels in the microenvironment of cells or
tissues relative to the normal physiological state (demand does
not match supply), increases tissue perfusion, erythropoiesis and
oxygen delivery (Mairbaurl, 1994; Semenza, 2009, 2011). Hyper-
oxia has the reverse effect (Piantadosi, 1999b). When oxygen is
delivered in the tissues, cytochrome oxidase, the final enzyme in
the mitochondria electron transport chain uses the oxygen as the
final electron acceptor to generate ATP.
In addition nitric oxide synthase isoforms utilize molecular
oxygen together with NADPH and arginine as substrates to gen-
erate NO, an important signaling molecule in the central nervous
system (CNS) and peripheral nervous system (Robinson et al.,
2011). NO can also be generated from a reaction between deoxy-
hemoglobin and nitrite following oxygen delivery or in hypoxic
conditions (Huang et al., 2005).
The microcirculation is facilitated by cellular adaptations to
hypoxia which includes improved ventilation and lung perfusion,
augmented cardiac contractility, increased vasodilation and regu-
lated ATP release (Jagger et al., 2001; Sprague et al., 2007; Gladwin
and Kim-Shapiro, 2012). At the molecular level, a transcription
factor, hypoxia inducible factor (HIF) coordinates the responses
to hypoxia (Semenza, 2009; Scholz and Taylor, 2013) through
the activity of hydroxylases. When oxygen is available, hydrox-
ylases (which are absolutely dependent on molecular oxygen)
FIGURE 1 | Organization of the β globin genes on chromosome 11. Gene expression occurs sequentially from the 5′ region in ontogenesis. The lightly shaded
rectangle represent a pseudogene.
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are activated to hydroxylate HIF for degradation, whereas lim-
ited oxygen supply leads to HIF stabilization and expression of
genes affecting vascular tone, erythropoiesis, angiogenesis and
metabolism (Schofield and Ratcliffe, 2005; Taylor, 2008; Eltzschig
and Carmeliet, 2011). These coordinated activities ensure a
smooth link for delivery of oxygen and nutrients to tissues with
removal of waste and carbon dioxide, so that adequate blood
flow through the microcirculation and attendant oxygen sup-
ply is maintained for cell health and survival. Decreases in rbc
hemoglobin as occurs in hemolysis, or pathological states such
as sickle cell disease, malaria, paroxysmal nocturnal hemoglobin-
uria (PNH), directly leads to decrease in tissue oxygen delivery
with attendant pathological consequences (Sikora et al., 2014).
The process of oxygen delivery is also regulated by allosteric
factors including protons (H+), CO2, organic phosphates, chlo-
ride (Cl-) and 2,3-bisphosphoglycerate (Mairbaurl and Weber,
2012). Structural changes at the molecular level in hemoglobin
that alters the affinity of themolecule for oxygen or its response to
the allosteric modulators, also contribute to the reversible bind-
ing to oxygen. The primary function of Hb in oxygen delivery is
clearly also coupled to maintaining energy homeostasis, through
processes that augment oxygen availability to cells and tissues.
Hemoglobin and CO2
In contrast to oxygen, carbon dioxide is generated in multi-
cellular organisms through the TCA cycle and during aerobic
metabolism (Buck and Levin, 2011; Cummins et al., 2014). Car-
bon dioxide not only contributes to the buffering system in blood
but also engages in signaling activity in critical life processes
including sperm activation, blood flow and dampening inflam-
mation (Boatman and Robbins, 1991; Buck and Levin, 2011; Tay-
lor and Cummins, 2011; Cummins et al., 2014). As part of the
buffering systems in the blood, the enzyme carbonic anhydrase
hydrates CO2 to H2CO3 which is transported to the lungs where
it readily dissociates through the activity of carbonic anhydrase to
HCO−3 and H+, with CO2 release and exhalation. Any remain-
ing carbon dioxide in tissues is bound by hemoglobin and sent
through the circulation to the lungs for exhalation. A decrease in
pH or an increase in the partial pressure of oxygen (PO2) in the
pulmonary capillaries decreases the affinity of CO2 for Hb lead-
ing to the release of CO2 from the blood and exhalation (Haldane
effect), (Dash and Bassingthwaighte, 2006).
Elevation in carbon dioxide modulates immune response
through inhibition of NF-κB, IL-6, TNF-alpha and mast cell
degranulation (Oliver et al., 2012; Cummins et al., 2014). These
activities lead to reduced inflammatory response. Carbon diox-
ide sensing is also known to inhibit innate immune response by
altering NF-kB signaling (Helenius et al., 2009; Cummins et al.,
2014). One of the major roles of CO2 sensing is the regulation
of the signaling activity of adenylyl cyclase to generate cAMP
(Kamenetsky et al., 2006). The latter function is particularly
important as cAMP is generated in microdomains throughout
the cell to fine tune intracellular signals through the activity of
soluble adenylyl cyclase (sAC) (Oliver et al., 2012). sAC is not
dependent on G-protein signaling but rather intracellular sig-
nals such as HCO−3 , calcium and ATP (Cummins et al., 2014).
In this regard sAC also participates in CO2 dependent regulation
of ATP generation depending on the amount of CO2 released in
the metabolic activity of the cell (Buck and Levin, 2011). Two sig-
naling activities of sAC that requires mentioning in this review
are the bicarbonate dependent activation of sperm to swim in
the female reproductive tract in a process referred to as capaci-
tation and bicarbonate dependent beating of cilia in the alveolar
epithelial cells that help in defense against inhaled pathogens or
particles (Huckstepp and Dale, 2011). So capacitation for life’s
beginnings and salutary cellular activities are important func-
tions of carbon dioxide sensing modulated by Hb. If one con-
siders that the partial pressure of CO2 regulates ventilation rate
and variations in pH and HCO−3 in the cell can elicit responses
such as changes in breathing rate, metabolism, fertility, immune
response and gene expression, Hb binding to CO2 indirectly
modulates these processes that contribute to the foundation of
life, its sustenance and maintenance of optimal health through
signaling function that protects against pathogens and subdue
inflammation.
Hemoglobin and NO
Nitric oxide (NO) is an important signaling molecule, recognized
in the Nobel Prize award in 1998 for Physiology and Medicine
(Butler, 2006). It is produced in mammalian cells mainly by enzy-
matic and non-enzymatic mechanisms. The enzymatic mecha-
nism is through nitric oxide synthase which is found in three
different isoforms (nNOS:NOS I, iNOS:NOS II, eNOS) depend-
ing on the cell source; n:neurons, i: inducible (macrophages
mainly and sometimes hepatocytes), and e: endothelium (Alder-
ton et al., 2001). Themain substrate for the enzymes is L-arginine,
which is transported into cells by the cationic amino acid
transporters (CAT) (Alderton et al., 2001; Hill et al., 2010).
The co-substrates are reduced nicotinamide adenine dinucleotide
phosphate (NADPH) and oxygen while tetrahydrobiopterin
(BH4), flavin adenine dinucleotide (FAD) and flavin mononu-
cleotide (FMN) function as cofactors modulated by calmodulin
in the redox reaction (Stuehr, 2004; Stuehr et al., 2004). The
non-enzymatic source of NO is largely from nitrites (Lundberg
and Weitzberg, 2010). Deoxyhemoglobin and deoxymyoglobin
by virtue of their nitrite reductase activity (Curtis et al., 2012;
Gladwin and Kim-Shapiro, 2012; Kapil et al., 2014; Gao et al.,
2015) react with nitrites to generate NO under tissue hypoxia or
ischemia. NO acts as a toxin and signaling molecule. The toxic
effect is in the generation of ROS (peroxynitrite) from interac-
tion with heme (ferrous iron) or hemin (ferric iron) following Hb
auto-oxidation to generate superoxide (Pacher et al., 2007; Beck-
man, 2009; Hill et al., 2010). This activity functions in the killing
of microbes but can also lead to damage of proteins, DNA and
lipids derived from peroxynitrite release (Koppenol, 2001). For
example NO is toxic to aconitase in the TCA cycle and heme-
copper terminal oxidases in the respiratory chain, responsible for
peroxynitrites generation, damage to DNA and release of lipid
radicals (Nathan and Ding, 2010; Forstermann and Sessa, 2012).
This obviously is a problem. Fortunately Hb also functions as
nitric oxide dioxygenase (NOD) converting nitric oxide and oxy-
gen to nitrates using NADPH as cofactor so that NO as a ROS
source is attenuated (Gardner, 2012). The NOD function of Hb
ensures continual energy supply necessary for homeostasis in
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cellular bioenergetics and reduction in potential damage to cells
from NOmediated ROS.
NO signaling is either through soluble guanylate cyclase (sGC)
to facilitate vascular homeostasis (blood flow) by modulating
vascular tone, inhibiting thrombosis and regulating the expres-
sion of endothelial adhesion molecules (Shiva et al., 2011) or
through modification of proteins by nitrosylation in metallopro-
teins, nitrosation or oxidation of protein side chains (Hill et al.,
2010; Haldar and Stamler, 2013). It is also important in skeletal
muscle contraction, CNS signaling and host resistance to infec-
tion. Hb NOD function also means that the role of NO as a
signaling molecule can be negatively affected, leading to reduced
blood flow. However, NO removal through NODmediated activ-
ity appears to correlate with activation of sGC so that steady state
levels are achieved. As a compensatory mechanism, Hb andmyo-
globin act as a sink for NO releasing it during times of need and
generate it from nitrites (Gardner, 2012).
Hemoglobin and CO
CO is produced in cells by heme oxygenase (HO encoded
by HMOX genes) mediated breakdown of heme to give CO,
biliverdin and iron (Fe2+) (Tenhunen et al., 1969). Two main
HO isoforms, HO-1 and HO-2 are known which are induced
and constitutive respectively (Tenhunen et al., 1969; Maines
et al., 1974; Yoshida and Kikuchi, 1974; Maines, 2000). HO-1 is
expressed basally in the liver and spleen while HO-2 is basally and
largely expressed in the brain (Immenschuh et al., 2010; Farrugia
and Szurszewski, 2014). Other minor sources include lipid perox-
idation and progesterone activity (Delivoria-Papadopoulos et al.,
1974; Wolff, 1976). Induced HO-1 expression is through a wide
variety of stimuli including inflammation, injury, ROS, hypoxia,
ischemia and hypothermia (Beckman et al., 2009; Immenschuh
et al., 2010; Kacimi et al., 2011). So cells that express HO-2 stably
produce CO, while stimuli dependent CO generation from HO-
1 expression varies depending on cellular environment (Farrugia
and Szurszewski, 2014).
CO is a signaling molecule with antioxidant and anti-
inflammatory activities (Farrugia and Szurszewski, 2014). It acti-
vates soluble guanylyl cyclase (Ramos et al., 1989; Lutz and
Bogdanova, 2013) to generate cyclic GMP (cGMP) for signal-
ing based on the cellular environment (Maines, 2000). In gen-
eral, the signaling function of CO parallels that of NO (although
not as potent) as a neuromessenger and regulator of vascular
tone (Furchgott and Jothianandan, 1991). The two gases are
involved in a negative feedback regulation with NO activating
HO-1 expression, while CO and HO-1 inhibit NO synthesis,
(White and Marletta, 1992; Durante et al., 1997; Zuckerbraun
et al., 2005). CO is biologically more stable thanNO and therefore
can exert effects distant from its site of production in addition
to local effects (Farrugia and Szurszewski, 2014). The functional
activity of CO relates to its high affinity for transition metals.
Since iron is the most abundant transition metal in cells, CO
competes for binding to various heme proteins, particularly Hb.
It binds to hemoglobin with an affinity that is 210–250 times that
of molecular oxygen (Haldane, 1895; Nasmith andGraham, 1906;
Amano and Camara, 2013). Partial occupation of CO at the oxy-
gen binding site of Hb, inhibits oxygen release from other heme
sites (Ryter and Choi, 2013). Hemoglobin can therefore scavenge
cellular CO to reduce its physiological impact but at the same
time render it incapable of carrying oxygen. The baseline car-
boxyhemoglobin (CO-Hb) level in man is 0.1–1.0% (Rudra et al.,
2010). If this level reaches 10–30%, it may cause headache, dizzi-
ness and shortness of breath (Gorman et al., 2003; Sen et al., 2010;
La Fauci et al., 2012). Levels above 30% are harmful and can lead
to severe headache, vomiting, syncope, cardiac arrhythmias and
death (Piantadosi, 1999a; Gorman et al., 2003).
The brain maintains the highest expression of HO, highlight-
ing the importance of CO as a signaling molecule in the brain
(Leﬄer et al., 2011). In the brain, CO dilates cerebral arteries
and arterioles by activating smooth muscle large conductance
Ca2+ activated K+ channels or “Big potassium” channel (BKca)
(Leﬄer et al., 2011) by a mechanism that is unrelated to sGC
activation (Koneru and Leﬄer, 2004; Telezhkin et al., 2011). The
activation of BKca channel activity leads to vasodilation promot-
ing brain vascular system health. CO also provides protection
for the cerebral vasculature (Parfenova et al., 2005). In hemol-
ysis, when heme availability is augmented, heme binding to the
BKca channel deactivates it, which is reversed through CO bind-
ing. Therefore, CO generation in hemolysis makes regulation of
the CO concentration particularly important during ischemia-
reperfusion not only in the brain but also in transplantation
(Sata et al., 2001). CO has emerged as a choice therapeutic agent
in cerebral malaria (CM). CM is a life threatening neurologi-
cal complication of Plasmodium falciparum infection in children
and adults, with the majority of cases (>90%) occurring in chil-
dren <5 years old in sub-Saharan Africa (Pena et al., 2012; Mur-
ray et al., 2014a; Christensen and Eslick, 2015). The incidence
rate is 1120/100,000 annually in endemic Africa, with mortal-
ity of 13-20% (Idro et al., 2010b; Postels and Birbeck, 2013).
Surviving children from the disease endure long term neuro-
logical and cognitive deficits (Brewster et al., 1990; Idro et al.,
2010a; Postels et al., 2012). Although the pathophysiology is not
completely known, current understanding outlines sequestration
of infected RBC leading to changes in brain microcirculation,
cerebral inflammation, vascular dysfunction and breakdown in
blood brain barrier (Shikani et al., 2012; Postels and Birbeck,
2013). Using P. berghei ANKA mouse models, HO-1/CO was
shown to completely inhibit CM and facilitate the resolution
of inflammation in the disease state (Pamplona et al., 2007;
Pena et al., 2012). Because of the potential danger of CO bind-
ing to heme containing molecules in particular Hb, CO releas-
ing molecules with limited formation of CO-Hb are now being
developed (Motterlini et al., 2005; Vera et al., 2005) for CM
treatment. CO is also under evaluation for use as a vasodilator
and inhibitor of ischemia reperfusion injury, an immunosup-
pressant in transplantation, (Sato et al., 2001; Otterbein et al.,
2003), and as an anticancer agent (Wegiel et al., 2013). Additional
roles of CO that are gaining attention include modulation of the
innate and adaptive immune response, inflammation (Otterbein
et al., 2000), cell proliferation, (Morita et al., 1997) apoptosis
(Brouard et al., 2000), mitochondrial biogenesis (Suliman et al.,
2007) and autophagy (Lee et al., 2014). Clearly Hb as a source of
CO and scavenger of CO confers significant salutary impact on
brain health (facilitating nutrient and oxygen delivery, limiting
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inflammation) and enabling maintenance of healthy cerebral
vasculature.
Hemoglobin as an Antioxidant/Defense Molecule
Hemoglobin in other vertebrates contains a number of thi-
ols that exert antioxidant defenses (Moleirinho et al., 2013). In
humans only one reactive cysteine is present at the 93rd posi-
tion of the β-chain (Vitturi et al., 2013). The Hb β93 cysteine
has been observed to moderate heme reactivity leading to auto-
oxidation (Balagopalakrishna et al., 1998). It scavenges reactive
species (hydrogen peroxide and superoxide anion) generated in
the heme pocket of the β-globin chain while inhibiting the activ-
ity of nitrosating and alkylating agents (Bonaventura et al., 1999;
Vitturi et al., 2013). The mechanism of scavenging of hydrogen
peroxide and superoxide anion appears to be the provision of
safe transfer of electrons to traditional antioxidant systems in
the rbc (Winterbourn and Carrell, 1977). This activity is most
effective under high oxygen tension (21%), when the risk of auto-
oxidation is high, being lost at 4% oxygen saturation (Benesch
and Benesch, 1962). When the total concentration of Hb in cir-
culation is taken into consideration, this will have a significant
bearing on cellular defense against hydrogen peroxide reactivity,
generation of ROS and hemoglobin auto-oxidation.
Hb in Cellular Immune Modulation
Central to cellular defense is the host immune response which
adapts to confer protection against infection or tissue damage.
The cells at the center of this adaptation are the myelomonocytic
cell lineage (de Back et al., 2014; Hamilton et al., 2014; Muraille
et al., 2014). In the event of an inflammation or infection,
the blood monocytes are recruited into tissues where they
mature into macrophages or dendritic cells (Geissmann et al.,
2003). Macrophages are polarized into M1 and M2 phenotypes
depending on the type of stimuli they receive and cytokine
profile they generate. In general M1 macrophages are elicited
by pro-inflammatory stimuli, while M2 macrophages by anti-
inflammatory stimuli (Lawrence and Natoli, 2011; Muraille et al.,
2014). In the scheme of activities of hemoglobin modulation of
the generation and function of the gaseous molecules NO, CO,
and CO2, hemoglobin will indirectly influence the M1 and M2
macrophage phenotype and therefore the TH1 and TH2 immune
cytokine profiles, (Lee and Chau, 2002; Alcaraz et al., 2003; Mur-
ray et al., 2014b). This will have significant implication for cellu-
lar defense against damage and pathogens through modulation
of TH1 and TH2 responses (Figure 2). This function requires
further interrogation.
Summary: Hemoglobin: Life’s Pivotal Heart Beat
In the natural environment hemoglobin is the support base for
life, ensuring that vital solar energy captured by plants for pho-
tosynthesis with release of oxygen is channeled to humans and
vertebrates to sustain the energy requirements of cells and life.
It supports life processes by binding to gaseous molecules with
major functions of efficient blood flow in the vasculature, oxy-
gen delivery and bioenergetics homeostasis. The cumulative pro-
cesses for oxygen supply and delivery to tissues is associated with
FIGURE 2 | Hemoglobin functional activities in promoting rbc and cellular health. (see text for details). *Binding of Hb to CO2 is through terminal α-amino
groups of Hb in contrast to the other gases.
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modulation of activities that not only constitute a threat to vas-
cular health but also cellular health in general. These activities
which include mitochondria biogenesis, signaling functions, reg-
ulation of inflammation, immune responses and cell viability,
palpably projects Hb as life’s pivotal heart beat (Figure 3) without
which evolution of life on earth would have been impossible.
Hemoglobin Mediated Tissue Injury: The
Foe
The damaging role of Hb under stress or pathological conditions
fall under four categories:
(a) Hemoglobin auto-oxidation within the rbc
(b) Hemoglobin release outside of its confines in rbc to act as
ROS source in the vasculature and tissues
(c) Hemoglobin scavenging of NO
(d) Heme release from Hb to augment free radical generation
For reviews covering these topics the reader is referred to Olsson
et al. (2012), Schaer et al. (2014), Rother et al. (2005), Larsen et al.
(2012), Gladwin and Sachdev (2012) and Tolosano et al. (2010).
So, how does Hb that provides such a strong support base for life
turn into an enemy?
Hb Auto-Oxidation
In general oxygen reversibly binds to Hb without any change
in the redox state of iron (Bonaventura et al., 2013). How-
ever, at physiological pH, O2 has a higher redox potential than
aqueous iron (Fe3+/Fe2+) so oxygen coordinated to heme in
hemoglobin accepts an electron from Fe2+ heme to form super-
oxide (O−2 ) with oxidation of Fe
2+ to Fe3+ generating met-
hemoglobin (hemin) in a stable complex (HbFe3+)O−2 , (Weiss,
1964; Faivre et al., 1998; Gardner, 2012). This process is Hb auto-
oxidation which is enhanced at acidic pH (low oxygen tension)
but reduced at high oxygen tension (Faivre et al., 1998; Aranda
et al., 2009; Bonaventura et al., 2013). Within the confines of the
rbc, antioxidants enable reduction of Ferric ion to the Fe2+ state
(Antonini, 1974; Edsall, 1986) so that Fe3+ is depleted to cause
no damage. Outside of the rbc auto-oxidation is high posing
significant danger.
Injury Associated with Hb Auto-Oxidation and
Release Outside of the rbc
Outside of the rbc, the major antioxidants are haptoglobin
for Hb (Schaer et al., 2014) and hemopexin, albumin, and
α-1 microglobulin (Fasano et al., 2007; Nordberg et al., 2007;
Tolosano et al., 2010) for heme. When hemolysis is severe the
capacity of the antioxidants to scavenge is overwhelmed, so
metHb and superoxide persist from Hb oxidation to set a cas-
cade of free radical generation to be described presently. First
released hemoglobin is closer to the vascular endothelium and
can also extravasate into tissues as dimers so that ROS generated
in auto-oxidation readily access macromolecules and cause dam-
ages (Nathan and Cunningham-Bussel, 2013; Dutra et al., 2014).
In that scenario tissue NADPH oxidases and vascular NADPH
oxidases facilitate the generation of hydrogen peroxide from
superoxide (Klebanoff, 2005). Superoxide also undergoes dismu-
tation by dismutase (superoxide dismutase) to generate hydrogen
peroxide which can further oxidize oxyHb/Met-Hb to the fer-
ryl (Fe4+ = O2−) form and in the process produce hydroxyl
radical (OH−) through Fenton chemistry (O•−2 + H2O2 →
O2 + OH
−
+ OH−), (Brawn and Fridovich, 1980; Klebanoff
et al., 1989; Pastor et al., 2000; Liochev and Fridovich, 2002).
These are highly reactive species that react with globin chains
and porphyrin rings to form globin and porphyrin ring radi-
cals (Alayash, 2011), DNA to form adducts and lipids to form
peroxides (Cadet et al., 1999; Marnett et al., 2003). The oxi-
dized hemoglobin species may resist scavenging and sustain tis-
sue injury, particularly the vascular endothelium (Goldman et al.,
1998; Rother et al., 2005). Moreover when superoxide is formed
in large quantities, because NO has a free electron in its outer
shell it can react with the superoxide to form peroxynitrite rad-
ical (ONOO−) which has a high reactivity with heme or hemin
and cellular macromolecules (Brawn and Fridovich, 1980; Halli-
well, 1996; Burney et al., 1999; Marnett et al., 2003). Hydrogen
peroxide can also cause intermolecular cross linking of tyrosine
FIGURE 3 | Hemoglobin: life’s core friend in sustaining cardiovascular health. Hb binding to gaseous molecules through heme (O2, CO, NO) or terminal
α-amino groups of Hb (CO2) facilitates cardiovascular function and health.
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residues in the globin chains which are reported to contribute
to atherosclerotic plaques in cardiovascular disease (Doyle et al.,
1985; Halliwell et al., 1999). So severe intravascular and extravas-
cular hemolysis lead to the damage of the vasculature as are
exposed cells and tissues at the cell membrane, mitochondria and
cytoskeleton, a very unfriendly, foe type activity arising from Hb.
Hb and NO Scavenging
Hemoglobin reacts rapidly and irreversibly with nitric oxide
(107m−1 s−1) to generate metHb and nitrate. The rate of this
reaction is such that a very small quantity of Hb can cause
significant NO depletion (Olson et al., 2004). The significance
of this activity was demonstrated in the reversal of acetyl-
choline mediated aortic arc relaxation in rabbits by cell free
Hb at concentrations >1mg/ml (Nakai et al., 1996). NO is
an important signaling molecule in maintaining vascular tone
and blood pressure, angiogenesis, platelet function, vascular
smooth muscle cell proliferation and inflammation (Shaul, 2002;
Sessa, 2004; Atochin and Huang, 2011) as alluded to previ-
ously. By scavenging NO, cell free Hb significantly impair vas-
cular function, bioenergetics homeostasis and portend significant
morbidity.
Heme Release from Cell Free Hb
Oxidized and denatured hemoglobins lose their attached heme
readily leading to heme mediated ROS generation (Balla et al.,
1991a,b). Heme mediated ROS generation is largely attributed to
the redox function of iron, which mediates reductive or oxida-
tive reactions involving the transfer or acceptance of electrons
(Dutra et al., 2014). This redox function makes Hb also function
as a major inducer of ROS because of its large concentration in
the rbc (Jeney et al., 2013). Heme is lipophilic and can interca-
late into cell membranes to disrupt membrane integrity (Schmitt
et al., 1993). Other downstream processes follow similar path to
that outlined for Hb auto oxidation which involves generation of
free radicals (Huertas and Palange, 2011; Dutra and Bozza, 2014)
pro-inflammatory activities and cytotoxicity (Larsen et al., 2012).
The scavenger proteins haptoglobin (Hp) and hemopexin (Hpx)
will normally scavenge cell free Hb and heme respectively obvi-
ating any ROS related activity if not in excess (Hvidberg et al.,
2005; Quaye, 2008; Tolosano et al., 2010; Schaer et al., 2014).
Hb bound haptoglobin is targeted for elimination through the
monocyte/macrophage scavenger receptor CD163 (Schaer et al.,
2014) while is heme first bound by albumin, transferred to Hpx
and the heme-Hpx complex targeted for clearance by the LDL
receptor related protein 1 (LRP 1/CD91 in hepatocytes in partic-
ular (Ascenzi and Fasano, 2007; Schaer et al., 2014). In addition
heme can also be scavenged by α-1 microglobulin (Allhorn et al.,
2002) and high density lipoproteins (Miller and Gladwin, 2012).
When levels of these proteins fall due to excessive hemolysis
then cellular/tissue damage is cascaded. For further reading the
reader is referred to Schaer et al. (2014), Tolosano et al. (2010),
Alayash (2011), Kristiansen et al. (2001), Nielsen and Moestrup
(2009), Hrkal and Klementova (1984), Balla et al. (1991b), Hvid-
berg et al. (2005), Dutra and Bozza (2014) and Dutra et al.
(2014).
Mechanism of Hb Release
Red blood cells lack a nucleus or mitochondria so injury mainly
affects the cell membrane leading to cell rupture and release
of hemoglobin either extra-vascularly or intra-vascularly (Balla
et al., 1991b). In severe insults (infection, complement fixation
and activation, trauma) where the rbc membrane is compro-
mised, hemoglobin is released outside of its confines in the rbc
posing danger not only to the vasculature but also to exposed tis-
sues following extravasation (Jeney et al., 2013; Dutra et al., 2014;
Schaer et al., 2014).
Extravascular and Intravascular Hemolysis
Human red blood cells have a normal life span of 120 days (Dhali-
wal et al., 2004; Sugawara et al., 2010). If this life span is curtailed
either through breakdown of the cell within the blood vessel or
outside of the vessels leading to the release of hemoglobin, the
process is referred to as intravascular or extravascular hemolysis
respectively (Dhaliwal et al., 2004; Sugawara et al., 2010; Mair-
baurl, 2013). Normally when hemoglobin reaches a life span of
120 days, it is removed by the spleen, bone marrow macrophage
phagocytosis and liver Kupffer cells. Part of the trigger for
removal is the presence of Heinz bodies which are aggregates of
oxidized or denatured hemoglobin in the rbc, Howell-jolly bodies
(inclusions of nuclear chromatin), siderocytes (rbcs with granules
of iron that is not part of Hb) and Pappenheimer bodies (inclu-
sion bodies formed by phagosomes ingesting large amounts of
iron) (Winslow et al., 1978; Weatherall, 1995, 2011; Sugawara
et al., 2010). The process of rbc removal by the mononuclear
phagocyte system in the spleen in particular, does not lead to
lysis so endogenous antioxidants including glutathione, ascorbic
acid, catalase, glutathione peroxidase and peroxiredoxin-2 in the
rbc limit the release of hemoglobin extravascularly (Crespo et al.,
1987; Mohandas and Gallagher, 2008). Indeed some hemoglobin
may leak and trigger the release of reactive oxygen species but
this is limited with respect to severity as the hemoglobin scav-
enger receptor CD163, and heme scavenger receptor CD91 effec-
tively scavenge the released hemoglobin through haptoglobin and
hemopexin respectively (Kristiansen et al., 2001; Hvidberg et al.,
2005; Tolosano et al., 2010; Schaer et al., 2013, 2014). Hb can also
be released extravascularly from internal bleedings (trauma) due
to damaged micro- and macro blood vessels.
In intravascular hemolysis, rbcs break up during circulation
from oxidative stress, aging or infection releasing Hb directly into
the vasculature and subsequently heme (Rother et al., 2005; Jeney
et al., 2013; Schaer et al., 2014). Intravascular and extravascular
hemolysis serve as potent sources of free radicals that define the
hazardous nature of Hb. The amount of Hb released depends on
the degree of severity of the oxidative stress or pathological con-
dition which overwhelms natural antioxidants and scavengers in
the rbc and plasma.
Summary: Hemoglobin as a Danger Molecule
Outside of its Confines
In severe extravascular and intravascular hemolysis Hb assumes a
foe like nature serving to propagate ROS generation, disrupt cell
membranes and cell function, the very activities that it supports
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when confined. Fortunately, this foe like activities present under
abnormal conditions requiring external intervention. The nature
and type of the interventions present a challenge but also a major
focus of research the world over.
Conclusion
Hemoglobin is a support base for all life processes physiologi-
cally. In the normal, physiological conditions it is salutary, under
stress (infection or trauma) the nature that promotes cell health
is disrupted leading to real threat and danger to cell function and
survival.
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